Literature DB >> 11876582

A family study of the high-risk children of opioid- and alcohol-dependent parents.

Timothy E Wilens1, Joseph Biederman, Elizabeth Bredin, Amy L Hahesy, Ana Abrantes, Deborah Neft, Rachael Millstein, Thomas J Spencer.   

Abstract

In this article, the author sought to use a high-risk study design focused on the children of parents with opioid or alcohol use disorders and children of parents with no substance use disorder (SUD) to evaluate the specificity of the risk conferred by the type of parental SUD. Using structured psychiatric interviews, cognitive assessments, and measures of social, academic, and family functioning, the authors studied 96 families (187 parents and 183 children, mean age of 11.6 years). Sixteen families had parental opioid dependence (22 children, 64% male), 14 families had parental alcohol dependence (22 children; 59% male), and 66 families had no SUD (controls; 139 children; 58% male). Fifty-nine percent of children of opioid-dependent parents had at least one major psychopathological condition, compared to 41% of the alcohol group and 28% of the control group (p < 0.01). The children of opioid- and alcohol-dependent parents were of lower socioeconomic status and had significantly more diffculties in academic, social, and family functioning than did controls. Children of opioid- and alcohol-dependent parents have significantly higher rates of psychopathology as well as more difficulties in academic, social, and family functioning compared to the children of non-SUD parents. In addition, notable trends emerged for the opioid group to have more psychopathology and functional impairment than the alcohol group. With a growing consensus that certain risk factors for later SUD start in childhood with potentially treatable childhood-onset disorders, new preventive approaches for individuals at risk may be developed targeting childhood precursors of

Entities:  

Mesh:

Year:  2002        PMID: 11876582     DOI: 10.1080/10550490252801620

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  11 in total

1.  Poly-product drug use disparities in adolescents of lower socioeconomic status: Emerging trends in nicotine products, marijuana products, and prescription drugs.

Authors:  Mariel S Bello; Rubin Khoddam; Matthew D Stone; Junhan Cho; Yoewon Yoon; Jungeun Olivia Lee; Adam M Leventhal
Journal:  Behav Res Ther       Date:  2018-11-28

2.  Opioid and Substance Use Disorder and Receipt of Treatment Among Parents Living With Children in the United States, 2015-2017.

Authors:  Lisa Clemans-Cope; Victoria Lynch; Marni Epstein; Genevieve M Kenney
Journal:  Ann Fam Med       Date:  2019-05       Impact factor: 5.166

3.  Psychiatric disorders in inhalant users: results from The National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Li-Tzy Wu; Matthew Owen Howard
Journal:  Drug Alcohol Depend       Date:  2006-11-28       Impact factor: 4.492

4.  The Case for Examining and Treating the Combined Effects of Parental Drug Use and Interparental Violence on Children in their Homes.

Authors:  Michelle L Kelley; Keith Klostermann; Ashley N Doane; Theresa Mignone; Wendy K K Lam; William Fals-Stewart; Miguel A Padilla
Journal:  Aggress Violent Behav       Date:  2010

5.  Behavioral Couples Treatment for Substance Use Disorder: Secondary Effects on the Reduction of Youth Internalizing Symptoms.

Authors:  Michelle L Kelley; Adrian J Bravo; Abby L Braitman
Journal:  J Abnorm Child Psychol       Date:  2017-05

6.  The variety of ecstasy/MDMA users: results from the National Epidemiologic Survey on alcohol and related conditions.

Authors:  Li-Tzy Wu; Andy C Parrott; Christopher L Ringwalt; Chongming Yang; Dan G Blazer
Journal:  Am J Addict       Date:  2009 Nov-Dec

7.  Fetal substance exposure and cumulative environmental risk in an African American cohort.

Authors:  Chie Yumoto; Sandra W Jacobson; Joseph L Jacobson
Journal:  Child Dev       Date:  2008 Nov-Dec

Review 8.  Prenatal opioid exposure and vulnerability to future substance use disorders in offspring.

Authors:  Yaa Abu; Sabita Roy
Journal:  Exp Neurol       Date:  2021-01-29       Impact factor: 5.330

9.  Adoption of the 275-patient buprenorphine treatment waiver for treating opioid use disorder: A state-level longitudinal analysis.

Authors:  Hannah K Knudsen; Lewei Allison Lin; Michelle R Lofwall
Journal:  Subst Abus       Date:  2019-07-11       Impact factor: 3.984

Review 10.  Opioid Addiction, Genetic Susceptibility, and Medical Treatments: A Review.

Authors:  Shao-Cheng Wang; Yuan-Chuan Chen; Chun-Hung Lee; Ching-Ming Cheng
Journal:  Int J Mol Sci       Date:  2019-09-02       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.